San Diego-based medical devices firm, Dexcom, is bringing its wearable continuous blood glucose monitors (CGM) to the UK and Europe. The company has been working with a number of healthcare organisations in Europe for several years now, but this will be their first foray into the UK. Dexcom is leading the drive towards smaller, more accurate and less intrusive CGM sensors through a number of number of international collaborations, including a groundbreaking link-up with Google’s life sciences division, Google Verily. Dexcom has already signed an agreement with the German Health Ministry to improve "reimbursement of real-time CGM technology", and it is also working alongside Google Verily at its new R&D centre in Edinburgh to further improve the performance of its wearable.
San Diego-based medical devices firm, Dexcom, is bringing its wearable continuous blood glucose monitors (CGM) to the UK and Europe. The company has been working with a number of healthcare organisations in Europe for several years now, but this will be their first foray into the UK. Dexcom has already signed an agreement with the German Health Ministry to improve "reimbursement of real-time CGM technology", and it is also working alongside Google Verily at its new R&D centre in Edinburgh to further improve the performance of its wearable.